Today

Agents

Chat

Arena

Discover

More

App

Belite Bio, Inc: Leerink Partners raises target price to $215 from $185

BLTE•2026-11-13

Leerink Partners raised its target price for Belite Bio to $215 from $185.

Related News

C

Cushman & Wakefield names Enrica Bellei to cross-border luxury international role

CWK•2026-11-13

South Korea says Nvidia will keep GPU pledges after Huang's resignation

NVDA•2026-11-13

Oil prices set for second weekly decline as Trump sticks with Iran blockade

USO•2026-11-13

Yeti Holdings: Piper Sandler cuts to neutral from overweight, lowers target to $39 from $58

YETI•2026-11-13

BioMarin Pharmaceutical Inc.: Morgan Stanley cuts target price to $103 from $119

BMRN•2026-11-13

Belite Bio, Inc: Leerink Partners raises target price to $215 from $185 - BLTE News | Rallies